Companies: 10,795·Total market cap: $144.5T
Knight Therapeutics Inc.

Knight Therapeutics Inc.

GUD.TOTSXHealthcare● Active
$8.61
+$0.15(+1.77%)
Market Cap$844078767
P/E Ratio—
52W High$8.9
52W Low$5.66
Overview
股票排行：Drug Manufacturers - Specialty & Generic·Healthcare·查看全部市值排行 →

Knight Therapeutics Inc.（GUD.TO）股票概览

关键指标与盈利、估值、营收、股息等标签页深链。

FMP · GUD.TO · 截至 Jun 8, 2026

关键指标

EPS (TTM)$0.05gud.to eps ttm · gud.to earnings per shareEarnings history
PE Ratio (TTM)167.8×gud.to pe ratio ttm · gud.to price to earningsPE Ratio deep dive
Revenue (TTM)$510.5Mgud.to revenue ttm · gud.to annual revenueFull revenue history
Dividend Yield不分红does gud.to pay dividends · gud.to dividend yieldDividend history
Shares Outstanding99.6Mgud.to shares outstanding · gud.to floatShares outstanding history
Next EarningsAug 6, 2026Est.gud.to earnings date · gud.to next earningsEarnings history

探索 Knight Therapeutics Inc. 数据

gud.to stock data · financials
市值$844.1Mgud.to market cap · gud.to valuation
分析师预测$— · Buy
股息不分红does knight therapeutics inc. pay dividends · gud.to dividend yield
营收$450.1M+21.22%knight therapeutics inc. annual revenue · gud.to revenue
盈利EPS $-0.05-226.17%gud.to earnings · gud.to eps
市盈率167.8×gud.to pe ratio · gud.to price to earnings

财务快照

完整财报
FY 2025Revenue$450.1M▲ +21.22% YoY
202320242025
knight therapeutics inc. revenue · gud.to revenue 2025
FY 2025Net Income-$5.4M▼ 224.05% YoY
202320242025
knight therapeutics inc. net income · gud.to profit 2025
FY 2025EPS$-0.05▼ 226.17% YoY
202320242025
gud.to eps · knight therapeutics inc. earnings per share 2025
TTM:Revenue: $510.5MNet Income: $5.6MEPS: $0.05View income statement →

分析师评级与目标价

完整预测
SellBuy
Buy1 位分析师is gud.to a buy · gud.to analyst rating
Strong Buy
0
Buy
1
Hold
0
Sell
0
Strong Sell
0
12-Month Price Target
$—Low
$8.61Current
$—Avg Target
$—High
gud.to price target · gud.to 12 month forecast

合计: 1 · 买入占比: 100.0%

股票表现

完整历史
1D+1.77%
1W+6.56%
1M-0.92%
3M+39.77%
YTD+42.31%
1Y+43.02%
5Y+63.38%

关于 Knight Therapeutics Inc.

CEOSamira Sakhia
IPO DateMar 3, 2014
Employees745
CountryCA
Websitegud-knight.com

Knight Therapeutics Inc. a specialty pharmaceutical company, develops, acquires, in-licenses, out-licenses, markets, and distributes pharmaceutical and consumer health products, and medical devices i…

Drug Manufacturers - Specialty & GenericHealthcareTSXCA

what is knight therapeutics inc. · gud.to stock overview · knight therapeutics inc. company profile · who is knight therapeutics inc. ceo · gud.to TSX · knight therapeutics inc. headquarters · knight therapeutics inc. business segments

关于股票概览与关键数据

Knight Therapeutics Inc.（GUD.TO）是 Drug Manufacturers - Specialty & Generic 行业的 Healthcare 类公司，于 Mar 3, 2014 在 TSX 上市。截至最近交易日，GUD.TO 股价为 $8.61，市值约为 $844.1M。过去12个月累计回报 +43.02%，年初至今回报 +42.31%。

根据 1 位华尔街分析师，Knight Therapeutics Inc. 股票共识评级为Buy，12个月平均目标价为 $—。2025 财年 Knight Therapeutics Inc. 营收 $450.1M，净利润 -$5.4M。更多数据（营收历史、盈利、股息、市盈率）请使用上方标签页。

常见问题

截至最近一个交易日，Knight Therapeutics Inc.（GUD.TO）股价为 $8.61，在 TSX 上市，52周区间为 $5.66 – $8.90。

GUD.TO 最新股价GUD.TO quote todaylive ticker 实时行情
数据来源：Financial Modeling Prep最后更新：Jun 8, 2026本内容不构成投资建议